ArticlePloS one2014

Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.

Marion David et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.